Monday, May 28, 2018
Tags Drugmakers

Tag: Drugmakers

Jazz Pharmaceuticals to Settle U.S. Probe for $57 Million

By Nate Raymond BOSTON (Reuters) Jazz Pharmaceuticals Plc said on Tuesday it had agreed to pay $57 million to resolve a U.S. probe into its...

AstraZeneca Flop a Fresh Blow to Cancer Immunotherapy Combination

By Ben Hirschler LONDON (Reuters) The concept of combining two immunotherapy drugs to fight lung cancer - not so long ago one of the hottest ideas...

Germany’s Merck Seeks Partners for Cancer and Immune System Drugs

By Ludwig Burger and Patricia Weiss FRANKFURT (Reuters)  Merck KGaA will seek development partners for experimental treatments including tepotinib as the German company looks to licensing...

Shire Sells Cancer Drugs to Servier for $2.4 Billion as Takeda...

By Ben Hirschler LONDON (Reuters) Shire, the London-listed rare diseases specialist that is a potential takeover target for Japan's Takeda Pharmaceutical, is selling its oncology business...

Lonza’s Virus Factory Shows Gene Therapy’s Texas-Sized Promise

By John Miller ZURICH (Reuters) Swiss drugmaker-for-hire Lonza is betting that trillions of customized viruses made at a giant factory in Texas will be the lucrative...

South Africa May Ask Pharma Firms for Fee to Clear Drug...

By Wendell Roelf CAPE TOWN (Reuters) Drugmakers in Africa's largest pharmaceutical market may be asked to pay a "backlog fee" to help clear a pipeline...
banner